Skip to main content

Animations

MJFF Publications

6211 - 6220 of 9033 Results
Title
Year
  • Year
  • 2025
  • 2023
  • 2014
  • 2025
  • 2025
  • 2021
  • 2020
  • 2025
  • 2020
  • 2017
  • Summary Details
    OPEN
    Title: Association between Human Leukocyte Antigen Alleles and Neuropathological Outcomes in Lewy Body Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.78075
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Brain Degeneration in Synucleinopathies Based on Analysis of Cognition and Other Nonmotor Features: A Multimodal Imaging Study
    Journal Name: Biomedicines
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/biomedicines11020573
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.09.023
    Citation Count: 91
  • Summary Details
    OPEN
    Title: Molecular Insight into Amyloid Fibril-Templated Aggregation of Biomarkers
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acschemneuro.5c00103
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Investigating the impact of Cu2+ on α-synuclein aggregation: A single-molecule approach
    Journal Name: International Journal of Biological Macromolecules
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.ijbiomac.2025.142161
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Nurr1 repression mediates cardinal features of Parkinson’s disease in α-synuclein transgenic mice
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/hmg/ddab118
    Citation Count: 18
  • Private variants in PRKN are associated with late-onset Parkinson's disease
    2020
    Summary Details
    RESTRICTED
    Title: Private variants in PRKN are associated with late-onset Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.05.003
    Citation Count: 6
  • Summary Details
    RESTRICTED
    Title: Neurofibrillary tangles predict dementia in patients with carotid stenosis
    Journal Name: Journal of Vascular Surgery
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jvs.2025.02.007
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28424
    Citation Count: 59
  • Summary Details
    OPEN
    Title: Integrating Next-Generation Genomic Sequencing and Mass Spectrometry To Estimate Allele-Specific Protein Abundance in Human Brain
    Journal Name: Journal of Proteome Research
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jproteome.7b00324
    Citation Count: 56
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.